Contact this trialFirst, we need to learn more about you.
Alkylating agents
LP-300 + Chemotherapy for Lung Adenocarcinoma
Recruiting3 awardsPhase 2
Dallas, Texas
This trial is testing a new cancer drug combo to see if it's more effective than the current standard of care, in patients who have never smoked.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.